Graft-vs.-Host Disease

Welcome to the Graft-vs.-Host Disease Resource Center! Here you will find updated information, education, and other resources from the field of GVHD. We're excited to provide this offering to you and your colleagues. Take a look around, and send us your feedback to jadpro-editor@broadcastmed.com.

Jaime Shahan, MPAS, PA-C Physician Assistant, Hematology/ Oncology Simmons Comprehensive Cancer Center at Redbird, University of Texas Southwestern 

ASTCT: Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation

EBMT−NIH−CIBMTR Task Force Position Statement on Standardized Terminology & Guidance for Graft-versus-Host Disease Assessment

UpToDate: Treatment of Acute Graft-versus-Host Disease

NCCN Clinical Practice Guideline: Hematopoietic Cell Transplantation

EBMT-ASTCT-APBMT-CIBMTR Report on Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy

Graft-vs.-Host Disease Resource Center

Interview With Catherine Lee, MD, MS: Updates in GVHD Clinical Trials

ASTCT: Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation

EBMT−NIH−CIBMTR Task Force Position Statement on Standardized Terminology & Guidance for Graft-versus-Host Disease Assessment

UpToDate: Treatment of Acute Graft-versus-Host Disease

NCCN Clinical Practice Guideline: Hematopoietic Cell Transplantation

EBMT-ASTCT-APBMT-CIBMTR Report on Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy

Bone Marrow Transplantation

European Journal of Haematology

Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET-EVER trial

Blood

Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT

JAMA Dermatology

Patient-reported outcomes and mortality in cutaneous chronic graft-vs-host disease

Bone Marrow Transplantation

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

Transplantation and Cellular Therapy

Easix score correlates with endothelial dysfunction biomarkers and predicts risk of acute graft-versus-host disease after allogeneic transplantation

Bone Marrow Transplantation

Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor

Bone Marrow Transplantation

Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation

Transplantation Proceedings

Clinical and economic burden associated with acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in Germany

Bone Marrow Transplantation

Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study

Elevated Bilirubin Following Engraftment: Differentiating SOS/VOD From GVHD

Management of Chronic Oral GVHD in Patient with High-Risk AML and Mixed Chimerism

Patient With History of Acute Steroid-Dependent Skin GVHD Develops Chronic GVHD: Part 2